PlGF
PlGF (placental growth factor, encoded by the PGF gene) is a secreted growth factor of the PDGF/VEGF family that acts in angiogenesis and endothelial cell growth. It is also known as PlGF-2, PIGF, PLGF and PGFL. Browse Assay Genie's current range of PlGF research reagents below, or read on for the biology behind the target.
PlGF is a growth factor active in angiogenesis and endothelial cell growth, where it stimulates endothelial cell proliferation and migration. It binds the receptor FLT1/VEGFR-1. The isoform PlGF-2 additionally binds neuropilin-1 (NRP1) and neuropilin-2 (NRP2) in a heparin-dependent manner. UniProt also records that PlGF promotes tumour cell growth.
The protein is secreted and belongs to the PDGF/VEGF growth factor family. HGNC places the PGF gene in the VEGF family group. NCBI Gene describes it as enabling growth factor activity and being involved in positive regulation of cell population proliferation, with a predicted location in the extracellular region. Mouse and rat each carry an orthologous gene, Pgf, which allows the biology to be studied in common rodent models.
The gene has carried several names, including placental growth factor-like and placental growth factor, vascular endothelial growth factor-related protein, reflecting its relationship to VEGF. PlGF has been implicated in several diseases, including brain ischaemia, diabetic neuropathy, glioblastoma, myocardial infarction and pancreatic endocrine carcinoma. It is also reported as a biomarker in conditions such as artery disease, arthritis, epilepsy, limited scleroderma and pancreatic endocrine carcinoma, which makes it a frequent subject of both mechanistic and biomarker studies.
PlGF stimulates endothelial cell proliferation and migration, making it a standard factor for studying how new vessels form.
PlGF binds FLT1/VEGFR-1, and PlGF-2 also binds neuropilin-1 and neuropilin-2, allowing ligand-receptor relationships in the VEGF family to be dissected.
PlGF promotes tumour cell growth and is implicated in glioblastoma and pancreatic endocrine carcinoma, supporting cancer studies.
PlGF is implicated in myocardial infarction and brain ischaemia, and is reported as a biomarker in artery disease, arthritis and epilepsy.
PlGF is a secreted growth factor active in angiogenesis and endothelial cell growth, stimulating endothelial proliferation and migration. It binds the receptor FLT1/VEGFR-1, and the PlGF-2 isoform binds neuropilin-1 and neuropilin-2 in a heparin-dependent manner. It also promotes tumour cell growth.
The HGNC symbol is PGF, and aliases include PlGF-2, PIGF, PLGF, PGFL, SHGC-10760 and D12S1900. Earlier names were placental growth factor-like and placental growth factor, vascular endothelial growth factor-related protein. UniProt lists the protein as placenta growth factor.
Mouse and rat both have an orthologous Pgf gene. PlGF is implicated in brain ischaemia, diabetic neuropathy, glioblastoma, myocardial infarction and pancreatic endocrine carcinoma, and is a reported biomarker in several others. Check the datasheet of any product for its validated reactivity.
Other VEGF family members, their receptors and co-receptors, and angiogenesis-related targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P49763; product specifications from Assay Genie datasheets.